Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-016016
Filing Date
2025-04-28
Accepted
2025-04-28 16:05:54
Documents
22
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20044196x2_def14a.htm   iXBRL DEF 14A 1071914
4 GRAPHIC ny20044196x2_pc01.jpg GRAPHIC 662129
5 GRAPHIC ny20044196x2_pc02.jpg GRAPHIC 544860
6 GRAPHIC ny20044196x2_pvp01.jpg GRAPHIC 119282
7 GRAPHIC ny20044196x2_pvp02.jpg GRAPHIC 109172
8 GRAPHIC ny20044196x2_pvp03.jpg GRAPHIC 109590
9 GRAPHIC sig_dnguyen.jpg GRAPHIC 15325
10 GRAPHIC sig_larrymiller.jpg GRAPHIC 14251
  Complete submission text file 0001140361-25-016016.txt   6188869

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA siga-20250610.xsd EX-101.SCH 2837
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE siga-20250610_def.xml EX-101.DEF 1917
25 EXTRACTED XBRL INSTANCE DOCUMENT ny20044196x2_def14a_htm.xml XML 373307
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38436 | Film No.: 25880276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)